Sex and the Relationship Between Cardiometabolic Risk Factors and Estimated GFR Decline: A Population-Based Cohort Study
https://t.co/YHLDdBUKhV
@BrendaMRosales @MelWyld@angelacwebster @Nickii_dlm @syd_health#VisualAbstract
Sex and the Relationship Between Cardiometabolic Risk Factors and Estimated GFR Decline: A Population-Based Cohort Study
https://t.co/YHLDdBUKhV
@BrendaMRosales @MelWyld@angelacwebster @Nickii_dlm @syd_health#VisualAbstract
Our latest paper from the @syd_health and @UofGlasgow research collaboration describes the relationship between cardiometabolic risk factors and kidney disease in males and females in @AJKDonline. Worth a read!
We are conducting #research into whether #NLP (eg #LLMs like #ChatGPT) can reliably interpret text written by #doctors about #clinical decisions. If of interest please click on link to view anonymous survey and/or share Survey link in plain text format - https://t.co/OPTBdO5kxV
@KaitlinMayne @BJGPjournal Maybe… (let’s see what the regulatory bodies say!) Although those most likely to benefit from flozination are still likely to be those with heavy proteinuria!!
People with high-risk kidney disease can be identified using a simple tool: kidney failure risk equation
Our paper in @BJGPjournal suggests its potential usefulness is limited by low rates of albuminuria testing. This will also limit access to ‘flozins!
CKD: NICE guidelines on chronic kidney disease may improve referrals from primary care to nephrology clinics, but albuminuria testing rates must be improved for the full benefit to be realised https://t.co/3OpFzaypHG @sullivanmk8 @jennifer_s_lees
@BenElyan kicks off the 2022 @ScottishRenal medical abstract session. People with CKD are systematically excluded from cancer drug trials, limiting their access to the best treatments
presence & impact of #multimorbidity clusters on adverse outcomes-Patterns of multimorbidity & risk of adverse outcomes varied with declining eGFR. #chronicpain & #depression emerged as important, associated with adverse outcomes in multimorbidity https://t.co/9ZkNreX9Gk
Declining levels of eGFR can lead to varying patterns of multimorbidity and corresponding risk of adverse outcomes.
Read the study by Michael K. Sullivan and colleagues @UofGlasgow here:
https://t.co/UzqrjXGhXW
What combinations of health conditions co-exist at different levels of kidney function? 🫘📉
What is the impact on clinical outcomes? 🫀
Check out our new paper in @BMCMedicine
https://t.co/eMrFdL9tzr
Depression and chronic pain matter!
These conditions have impacts on the day-to-day lives of people, but we showed that when combined with physical conditions like diabetes and heart disease, the risk of adverse outcomes is increased.
£0 Who gets severe COVID-19 after vaccination? Pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales @TheLancet @DrAzizSheikh https://t.co/xr9gQkgUsI
@AghilesHamroun Thanks, Aghiles. Older adults, women and non-diabetics were less likely to have uACR testing. This might indicate where we need to improve testing
How can we improve referrals from primary care to the renal clinic?🏥🫘
Urine needs to be tested more often for protein!🧪
Our study shows that only around 25% of patients with kidney disease provide urine samples for testing. 🧵
https://t.co/UG79Vz0UpF